Landau Jeffrey B 4
4 · CytomX Therapeutics, Inc. · Filed Dec 22, 2023
Insider Transaction Report
Form 4
Landau Jeffrey B
Chief Business Officer
Transactions
- Sale
Common Stock
2023-12-20$1.38/sh−4,077$5,628→ 86,622 total
Holdings
- 4,500(indirect: By IRA)
Common Stock
- 3,180(indirect: By IRA)
Common Stock
Footnotes (2)
- [F1]The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of PSUs previously reported on December 19, 2023.
- [F2]Includes 52,205 restricted stock units.